REFERENCE
Srinivasulu Tirumalasetty
Global pharma News
WALK IN INTERVIEW @ STRIDES SHASUN LIMITED
Vacancies for API Quality and Manufacturing Operations:
Place of posting: Cuddalore
Quality Control:
Executive / Sr.Executive / Team Lead/Sr. Team Lead - Quality Control
Qualification and Experience: Any science graduate with 0 to 10 yrs exp in RM analysis, IPIM analysis, FB-HPLC analysis, Reviewer, QMS/AMT/AM and WS/calibrations.
Quality Assurance:
Executive / Sr.Executive / Team Lead / Sr Team Lead – Quality Assurance
Executive / Sr.Executive / Team Lead / Sr Team Lead – Quality Assurance
Qualification & Experience:
Any science graduate with 0 to 12 yrs exp in IPQA, BMR review, Dispatch, Engineering Assurance, Audit Responses, SAP, Document Assurance and APQR Cell.
Any science graduate with 0 to 12 yrs exp in IPQA, BMR review, Dispatch, Engineering Assurance, Audit Responses, SAP, Document Assurance and APQR Cell.
QC Microbiology:
Executive/Group Lead - QC (Microbiology)
Executive/Group Lead - QC (Microbiology)
Qualification and exp: M.Sc. Microbiology with 2 to 10 yrs exp in QC systems, GLC and SOPs.
Projects:
Sr.Team Lead - Civil/Mechanical
Sr.Team Lead - Civil/Mechanical
Qualification & experience:
B.Tec/BE Civil/Mechanical with 8+ yrs exp in supervision of construction works, preparation of budget estimates proposal and preparation of equipment layout and other drawings for construction process.
B.Tec/BE Civil/Mechanical with 8+ yrs exp in supervision of construction works, preparation of budget estimates proposal and preparation of equipment layout and other drawings for construction process.
Date:12th November 2016
Venue:
Strides Shasun Limited
"Batra Centre"
No.28, Sardar Patel Road
Guindy, Chennai - 6000032
Landmark: Back side of Ashok Leyland
Strides Shasun Limited
"Batra Centre"
No.28, Sardar Patel Road
Guindy, Chennai - 6000032
Landmark: Back side of Ashok Leyland
Contact: Vinoth Parthiban/Sathyeshraaj/Suganya
Mobile No.7373730801
Mobile No.7373730801
Thank you for visiting my blog , Visit again for latest pharma
updates